Zhejiang Hisun Pharmaceutical Co (SHSE:600267) EPS (Basic) : ¥0.52 (TTM As of Dec. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Zhejiang Hisun Pharmaceutical Co EPS (Basic)?

Zhejiang Hisun Pharmaceutical Co's basic earnings per share (Basic EPS) for the three months ended in Dec. 2024 was ¥0.08. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2024 was ¥0.52.

Zhejiang Hisun Pharmaceutical Co's EPS (Diluted) for the three months ended in Dec. 2024 was ¥0.08. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was ¥0.52.

Zhejiang Hisun Pharmaceutical Co's EPS without NRI for the three months ended in Dec. 2024 was ¥0.14. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2024 was 0.72.

During the past 12 months, Zhejiang Hisun Pharmaceutical Co's average EPS without NRIGrowth Rate was -53.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Zhejiang Hisun Pharmaceutical Co's highest 3-Year average EPS without NRI Growth Rate was 61.00% per year. The lowest was -108.00% per year. And the median was 15.25% per year.

Zhejiang Hisun Pharmaceutical Co EPS (Basic) Historical Data

The historical data trend for Zhejiang Hisun Pharmaceutical Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Hisun Pharmaceutical Co EPS (Basic) Chart

Zhejiang Hisun Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EPS (Basic)

Get a 7-Day Free Trial

0.43

0.42

-0.08

0.52

Zhejiang Hisun Pharmaceutical Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
EPS (Basic)	Get a 7-Day Free Trial															-0.46	0.21	0.16	0.07	0.08

Zhejiang Hisun Pharmaceutical Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Zhejiang Hisun Pharmaceutical Co's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(601.183	-	0)	/	1156.121
	=	0.52

Zhejiang Hisun Pharmaceutical Co's Basic EPS for the quarter that ended in Dec. 2024 is calculated as

Basic EPS (Q: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(85.87	-	0)	/	1110.986
	=	0.08

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.52

Zhejiang Hisun Pharmaceutical Co (SHSE:600267) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Zhejiang Hisun Pharmaceutical Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Zhejiang Hisun Pharmaceutical Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Hisun Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Hisun Pharmaceutical Co Ltd (SHSE:600267) » Definitions » EPS (Basic)

Traded in Other Exchanges

N/A

Address

No. 46 Waisha Road, Jiaojiang District, Zhejiang Province, Taizhou, CHN, 318000

Website

http://www.hisunpharm.com

Zhejiang Hisun Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is focused on the research, development, and distribution of pharmaceuticals. It produces and supplies antibiotics and anticancer drugs. The company's research channels cover indications like anticancer, cardiovascular, anti-infective, anti-parasitic, immunosuppressant and others. Its product portfolio includes active pharmaceutical ingredients like Anastrozole, Docetaxel, Methotrexate, and others and finished dosages such as letrozole tablets, anastrozole tablets, injection mitomycin, and others.

Executives

Yu Shun Bing	Supervisors
Jin Hong Shun	senior management
Lu Xing Hai	senior management
Zhang Zhen Ying	senior management
Jiang Guo Ping	Director
Yang Zhi Qing	senior management
Du Jia Qiu	senior management
Chen Xiao Hua	Directors, senior managers
Li Yan	Directors, senior managers
Zhao Lei	senior management
Shen Xi Fei	Director
Zhang Wei	senior management
Bai Hua	Director
Chen Li Fei	Supervisors
Hu Liang Bin	senior management

Zhejiang Hisun Pharmaceutical Co Headlines

No Headlines